MedPath

Safety and Efficacy of a Bausch & Lomb Multipurpose Solution When Compared to Ciba Vision Aquify Multipurpose Solution

Not Applicable
Completed
Conditions
Contact Lens Solutions
Interventions
Device: Bausch & Lomb Multipurpose Solution - No Rub Care
Device: Bausch & Lomb Multipurpose Solution - Rub Care
Device: Ciba Vision Aquify Multipurpose Solution
Registration Number
NCT00636363
Lead Sponsor
Bausch & Lomb Incorporated
Brief Summary

To the safety and efficacy of a Bausch \& Lomb Multipurpose Solution when compared to Ciba vision Aquify Multipurpose solution

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
541
Inclusion Criteria
  • subject is a habitual wearer of a silicone hydrogel or group IV contact lens
  • VA correctable to 0.3 LogMar or better (driving vision)
  • Clear central cornea
  • Subject uses a lens care system on a regular basis
Exclusion Criteria
  • Systemic disease affecting ocular health
  • Using systemic or topical medications
  • wear monovision, multifocal or toric contact lenses
  • Any grade 2 or greater slit lamp findings

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Multipurpose Solution - No Rub CareBausch & Lomb Multipurpose Solution - No Rub CareBausch \& Lomb Multipurpose Solution for use with contact lens care
Multipurpose Solution - Rub CareBausch & Lomb Multipurpose Solution - Rub CareBausch \& Lomb Multipurpose Solution for use with contact lens care
Ciba Vision Aquify Multipurpose SolutionCiba Vision Aquify Multipurpose SolutionCiba Vision Aquify Multipurpose Solution for use with contact lens care
Primary Outcome Measures
NameTimeMethod
Slit-lamp Findings > Grade 2Over 4 visits for 3 month period

eyes with any slit lamp findings greater than Grade 2 at any visit. Slit lamp findings for each eye will be graded for severity on a scale from 0 (No Finding) to 4 (Severe Finding). Epithelial edema, epithelial microcysts, corneal staining, limbal injection, bulbar injection, superior tarsal conjunctival abnormalities, corneal neovascularization, and corneal infiltrates will be assessed.

Subjective Responses to Comfort Related Symptoms/ComplaintsOver 4 visits for the 3 month period

Subject symptoms/complaints will be assessed on a scale from 0 to 100, with 0 denoting unfavorable symptoms/complaints.

Contact Lens DepositsAt each visit for 3 months

Lens deposits assessed at each follow-up visit. Degree of deposits assessed as none, light, medium, or heavy.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Place Eye Care

🇺🇸

LeRoy, New York, United States

© Copyright 2025. All Rights Reserved by MedPath